Crescent Capital BDC, Inc. (CCAP) To Go Ex-Dividend on December 31st

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) declared a quarterly dividend on Wednesday, November 13th,Wall Street Journal reports. Investors of record on Tuesday, December 31st will be given a dividend of 0.42 per share on Wednesday, January 15th. This represents a $1.68 annualized dividend and a dividend yield of 8.78%. The ex-dividend date is Tuesday, December 31st. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07.

Crescent Capital BDC has a payout ratio of 82.8% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline. Research analysts expect Crescent Capital BDC to earn $1.99 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 84.4%.

Crescent Capital BDC Price Performance

Shares of NASDAQ CCAP opened at $19.13 on Friday. Crescent Capital BDC has a 52 week low of $15.91 and a 52 week high of $19.63. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. The firm has a market cap of $708.96 million, a P/E ratio of 7.50 and a beta of 0.81. The business’s 50 day moving average price is $18.40 and its 200 day moving average price is $18.41.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.01. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. The firm had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. During the same quarter in the prior year, the business earned $0.56 earnings per share. On average, sell-side analysts expect that Crescent Capital BDC will post 2.35 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CCAP shares. Wells Fargo & Company reduced their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 14th. Bank of America dropped their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 15th. Finally, LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a research note on Monday, September 30th. They issued a “buy” rating and a $20.00 price target on the stock. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Crescent Capital BDC currently has an average rating of “Moderate Buy” and a consensus target price of $19.00.

Get Our Latest Analysis on Crescent Capital BDC

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Further Reading

Dividend History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.